We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Targeting HER2 in Advanced Solid Tumors: A Comprehensive Understanding of the Rationale and Potential Benefits
Shubham Pant, MD, MBBS
Targeting HER2 Across Advanced Solid Tumors
Susana Banerjee, MBBS, MA, FRCP, PhD
Brad McGregor, MD
Kathleen Moore, MD, MS
Addressing the Unmet Need in HER2-Positive Advanced Solid Tumors: Exploring Response Rates and Duration of Response
Testing for Solid Tumors: Tissue and Liquid Biopsy Approaches Using NGS Technologies for cfDNA and ctDNA Analysis
Maximizing Benefit with the Expanding Options for Gastric Cancer: Patient Selection and Management
James M. Cleary, MD, PhD
Kathleen Madden, FNP, MSN, AOCNP, APHN
Endometrial Cancer: HER2-Targeted ADCs: A Promising Approach to Address Unmet Needs
ASCO/ESMO 2023 Roundtable: Contextualizing the Latest Advances in HER2-Targeted Therapy for Solid Tumors
Management Strategies for Treatment-Emergent Adverse Events (TEAEs) in HER2-Altered Advanced Solid Tumors
Cervical Cancer: HER2-Targeted ADCs – Current Status and Future Directions
Ovarian Cancer: Advances in HER2-Targeted ADCs
Biliary Tract and Pancreatic Cancer: HER2-Targeted ADCs for Gastrointestinal Cancers
Targeting IL-13 in Moderate to Severe Atopic Dermatitis: Forging a New Path to Improved Disease and Patient Outcomes
Terry Faleye, MPAS, PA-C
Jonathan I. Silverberg, MD, PhD, MPH
Applying Novel Strategies to the Treatment of Advanced Renal Cell Carcinoma
Terran Sims, MSN, ACNP-C, CNN, COCN-C
Mary Weinstein Dunn
An Update on Biomarkers in NSCLC Clinical Management
Rasheda Persinger MSN, AGNP-C, AOCNP
PARP Inhibitors in Prostate Cancer: Improving Patient Outcomes Through Precision Therapy
Frank dela Rama, RN, MS, AOCNS, AGN-BC
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education